HealthDay - THURSDAY, May 10 (HealthDay News) -- The Neupro patch (rotigotinetransdermal system) has been approved by the U.S. Food and DrugAdministration as the first skin patch to treat symptoms of earlyParkinson's disease, the agency said Wednesday.
This site uses cookies to help personalise content, tailor your experience and to keep you logged in if you register.
By continuing to use this site, you are consenting to our use of cookies.